Sundan, Anders

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.

Standal, T., Seidel, C., Hjertner, Ø., Plesner, T., Sanderson, R. D., Waage, A., Borset, M., & Sundan, A. (2002) · Blood

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 244

Interleukin-21 is a growth and survival factor for human myeloma cells

Brenne, A.-T., Baade Ro, T., Waage, A., Sundan, A., Borset, M., & Hjorth-Hansen, H. (2002) · Blood

Multiple Myeloma Research and TreatmentsCytokine Signaling Pathways and Interactions

Cited by 168

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Standal, T., Abildgaard, N., Fagerli, U.-M., Stordal, B., Hjertner, Ø., Borset, M., & Sundan, A. (2007) · Blood

Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments

Cited by 167

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.

Hjorth-Hansen, H., Seifert, M. F., Börset, M., Aarset, H., Östlie, A., Sundan, A., & Waage, A. (1999) · Journal of Bone and Mineral Research

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 71

A Gain-of-Function Mutation in EPO in Familial Erythrocytosis

Zmajkovic, J., Lundberg, P., Nienhold, R., Torgersen, M. L., Sundan, A., Waage, A., & Skoda, R. C. (2018) · New England Journal of Medicine

Erythropoietin and Anemia TreatmentHemoglobinopathies and Related Disorders

Cited by 56

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids

Wang, H., Teriete, P., Hu, A., Raveendra-Panickar, D., Pendelton, K., Lazo, J. S., Eiseman, J., Holien, T., Misund, K., Oliynyk, G., et al. (2015) · Oncotarget

Natural Compounds in Disease TreatmentNatural product bioactivities and synthesis

Cited by 53